SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-108092
Filing Date
2020-04-15
Accepted
2020-04-15 16:06:13
Documents
9
Period of Report
2020-04-14
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d866892d8k.htm 8-K 34963
2 EX-1.1 d866892dex11.htm EX-1.1 293843
3 EX-5.1 d866892dex51.htm EX-5.1 19008
4 EX-99.1 d866892dex991.htm EX-99.1 16011
5 EX-99.2 d866892dex992.htm EX-99.2 16243
6 GRAPHIC g866892ex5-1001.jpg GRAPHIC 4155
7 GRAPHIC g866892ex5-1002.jpg GRAPHIC 3434
8 GRAPHIC g866892ex99-1001.jpg GRAPHIC 9478
9 GRAPHIC g866892ex99-2001.jpg GRAPHIC 9478
  Complete submission text file 0001193125-20-108092.txt   418310
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 20793824
SIC: 2834 Pharmaceutical Preparations